🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Venous Thromboembolism

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients NCT06357403n/a3 sites📍 Graz📍 Innsbruck📍 Vienna Medical University of Vienna · Tests: Anti-factor Xa activity calibrated for enoxaparin Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters NCT05029063Phase 311 sites📍 Halifax📍 Brampton📍 Hamilton Ottawa Hospital Research Institute · Tests: Rivaroxaban 10 MG START-Register: Survey on Anticoagulated Patients Register NCT02219984n/a1 site📍 Bologna GUALTIERO PALARETI · Tests: Anticoagulants Filter Initial & Long Term Evaluation After Placement and Retrieval Registry NCT01158482n/a1 site📍 Stanford Stanford University · Tests: IVC Filter Placement or Retrieval Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee Arthroplasty NCT07869615NA1 site📍 Tunis Military Hospital of Tunis · Tests: Apixaban, Rivaroxaban, Enoxaparin (LMWH) Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer NCT07288632n/a1 site📍 Perugia University Of Perugia Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) NCT04257487Phase 31 site📍 Rozzano Arianna Anticoagulazione Foundation · Tests: Sulodexide, Sulodexide and placebo, Placebo Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study NCT05089227Phase 21 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: treatment "intervention", treatment "standard", biological assessment Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery NCT07439991n/a1 site📍 Changchun The First Hospital of Jilin University · Tests: Prospective Perioperative Data Collection The Frequency of Peripheral Arterial Disease in Patients with Deep Vein Thrombosis of the Lower Limbs NCT06806540n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Cancer-related Venous Thromboembolic Disease - Cohort Study NCT06393764n/a1 site📍 Brest University Hospital, Brest · Tests: Collection of biological samples Statins to Prevent Cancer Associated Blood Clots NCT07303816Phase 49 sites📍 Irvine📍 New Haven📍 Miami Brigham and Women's Hospital · Tests: Rosuvastatin, Placebo Drug Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study NCT05881798n/a7 sites📍 Los Angeles📍 Barcelona📍 Córdoba Cook Research Incorporated · Tests: Celect Platinum Vena Cava Filter Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis NCT06958588Phase 41 site📍 Belo Horizonte Science Valley Research Institute · Tests: Experimental: Hyperslim, Active Comparator #1 Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage NCT06753786NA1 site📍 Moscow Pirogov Russian National Research Medical University · Tests: Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the firs… Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) NCT03728166NA1 site📍 Boston Brigham and Women's Hospital · Tests: Electronic alert Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients NCT07856641n/a1 site📍 Houston The University of Texas Health Science Center, Houston Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention NCT07243080Phase 41 site📍 Lahore Mayo Hospital Lahore · Tests: rivaroxaban (10mg), Enoxaparin 40 mg SC PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) NCT03559114Phase 312 sites📍 Calgary📍 Edmonton📍 Edmonton Sunnybrook Health Sciences Centre · Tests: Dalteparin, Saline inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT NCT06581965Phase 413 sites📍 Apeldoorn📍 Geleen📍 Geldrop Leiden University Medical Center · Tests: Short duration prophylaxis, Higher intensity and longer duration prophylaxis, Control The Erlanger Stroke Registry (ESPro) is the Only Ongoing Prospective Population-based Stroke Registry in Germany, Started in 1994. ESPro Includes All Hospitalized and Non-hospitalized Patients With Stroke in the Community of Erlangen (120.000 Inhabitants), With a Long-life Follow-up. NCT07771335n/a3 sites📍 Erlangen📍 Erlangen📍 Erlangen University of Erlangen-Nürnberg Medical School Heat Shock Protein 47 in Thrombosis NCT06731673n/a2 sites📍 Aarhus📍 Berlin University of Aarhus Supplemental Oxygen in Pulmonary Embolism (SO-PE) NCT05891886EARLY Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Oxygen Therapy, Non-rebreather mask Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies NCT07270263NA1 site📍 Gdansk Medical University of Gdansk · Tests: Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) Apixaban in Thrombocytopenia NCT06886516EARLY Phase 11 site📍 Boston Rushad Patell · Tests: Apixaban Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable NCT07430956Phase 344 sites📍 Dothan📍 Glendale📍 Little Rock Regeneron Pharmaceuticals · Tests: REGN7508, REGN9933, Placebo Aspiration Thrombectomy Using the Symphony or Prodigy System NCT07350499n/a13 sites📍 Huntsville📍 Clearwater📍 Jacksonville Imperative Care, Inc. · Tests: Prodigy Thrombectomy System, Symphony Thrombectomy System, Symphony Thrombectomy System Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) NCT06440694Phase 34 sites📍 Ottawa📍 Windsor📍 Montreal Ottawa Hospital Research Institute · Tests: Colchicine 0.5 mg po, Placebo 0.5 mg po RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing NCT06195540Phase 337 sites📍 Agen📍 Angers📍 Argenteuil University Hospital, Angers · Tests: Rivaroxaban 10 MG, Low Heparin Molecular Weight Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial NCT06523959Phase 41 site📍 Helsinki Clinical Urology and Epidemiology Working Group · Tests: Apixaban 2.5 MG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy